Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria

Journal of Clinical Investigation

Volumn 126, Issue 10, 2016, Pages 4016-4029

  Gallego Delgado, Julio ^a   Basu Roy, Upal ^a   Ty, Maureen ^a   Alique, Matilde ^b   Fernandez Arias, Cristina ^a   Movila, Alexandru ^a   Gomes, Pollyanna ^a   Weinstock, Ada ^a   Xu, Wenyue ^a   Edagha, Innocent ^a   Wassmer, Samuel C ^a   Walther, Thomas ^c,d   Ruiz Ortega, Marta ^b   Rodriguez, Ana ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; BETA CATENIN; LEF PROTEIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; BIPHENYL DERIVATIVE; CTNNB1 PROTEIN, HUMAN; IRBESARTAN; TETRAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN PROTECTION; CAPILLARY ENDOTHELIAL CELL; CELL JUNCTION; CELL NUCLEUS; CEREBRAL MALARIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDOTHELIUM; ENDOTHELIUM CELL; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REGULATORY MECHANISM; SURVIVAL; TRANSCRIPTION REGULATION; BRAIN; CAPILLARY PERMEABILITY; CELL ADHESION; CELL CULTURE; MALARIA FALCIPARUM; METABOLISM; MICROVASCULATURE; NUCLEOCYTOPLASMIC TRANSPORT; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIMALARIALS; BETA CATENIN; BIPHENYL COMPOUNDS; BRAIN; CAPILLARY PERMEABILITY; CELL ADHESION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR JUNCTIONS; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MICROVESSELS; PLASMODIUM FALCIPARUM; RECEPTOR, ANGIOTENSIN, TYPE 2; TETRAZOLES;

EID: 84991717340     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI87306     Document Type: Article

References (55)

1. Storm J, Craig AG. Pathogenesis of cerebral malaria -inflammation and cytoadherence. Front Cell Infect Microbiol. 2014;4:100.
2. Avril M, et al. A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells. Proc Natl Acad Sci U S A. 2012;109(26):E1782-E1790.
3. Claessens A, et al. A subset of group A-like var genes encodes the malaria parasite ligands for binding to human brain endothelial cells. Proc Natl Acad Sci U S A. 2012;109(26):E1772-E1781.
4. Turner L, et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature. 2013;498(7455):502-505.
5. Dorovini-Zis K, et al. The neuropathology of fatal cerebral malaria in malawian children. Am J Pathol. 2011;178(5):2146-2158.
6. Brown HC, et al. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology. 2000;55(1):104-111.
7. Gillrie MR, et al. Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins. Blood. 2007;110(9):3426-3435.
8. Jambou R, Combes V, Jambou MJ, Weksler BB, Couraud PO, Grau GE. Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog. 2010;6(7):e1001021.
9. Wilson NO, et al. Soluble factors from Plasmodium falciparum-infected erythrocytes induce apoptosis in human brain vascular endothelial and neuroglia cells. Mol Biochem Parasitol. 2008;162(2):172-176.
10. Tripathi AK, Sha W, Shulaev V, Stins MF, Sullivan DJ. Plasmodium falciparum-infected erythrocytes induce NF-κB regulated inflammatory pathways in human cerebral endothelium. Blood. 2009;114(19):4243-4252.
11. Tripathi AK, Sullivan DJ, Stins MF. Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers. J Infect Dis. 2007;195(7):942-950.
12. Zougbédé S, et al. Metabolic acidosis induced by Plasmodium falciparum intraerythrocytic stages alters blood-brain barrier integrity. J Cereb Blood Flow Metab. 2011;31(2):514-526.
13. Steyers CM, Miller FJ. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15(7):11324-11349.
14. Brown H, et al. Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg. 2001;64(3-4):207-213.
15. Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003;24(9):491-499.
16. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004;84(3):869-901.
17. Kim H, Higgins S, Liles WC, Kain KC. Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics. Curr Opin Hematol. 2011;18(3):177-185.
18. Dvorin JD, et al. A plant-like kinase in Plasmodium falciparum regulates parasite egress from erythrocytes. Science. 2010;328(5980):910-912.
19. Baeyens N, Bandyopadhyay C, Coon BG, Yun S, Schwartz MA. Endothelial fluid shear stress sensing in vascular health and disease. J Clin Invest. 2016;126(3):821-828.
20. Adams Y, Rowe JA. The effect of anti-rosetting agents against malaria parasites under physiological flow conditions. PLoS One. 2013;8(9):e73999.
21. Fuerer C, Nusse R. Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLoS One. 2010;5(2):e9370.
22. Kim H, et al. Modulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nat Commun. 2013;4:2403.
23. Su JB. Vascular endothelial dysfunction and pharmacological treatment. World J Cardiol. 2015;7(11):719-741.
24. Dhangadamajhi G, Mohapatra BN, Kar SK, Ranjit M. Gene polymorphisms in angiotensin I converting enzyme (ACE I/D) and angiotensin II converting enzyme (ACE2 C→T) protect against cerebral malaria in Indian adults. Infect Genet Evol. 2010;10(2):337-341.
25. Chung O, Kühl H, Stoll M, Unger T. Physiological and pharmacological implications of AT1 versus AT2 receptors. Kidney Int Suppl. 1998;67:S95-S99.
26. de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology. 2010;137(5):755-772.
27. Engwerda C, Belnoue E, Grüner AC, Rénia L. Experimental models of cerebral malaria. Curr Top Microbiol Immunol. 2005;297:103-143.
28. Ichiki T, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995;377(6551):748-750.
29. Gallego-Delgado J, et al. Angiotensin II moderately decreases Plasmodium infection and experimental cerebral malaria in mice. PLoS One. 2015;10(9):e0138191.
30. Saraiva VB, et al. Impairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides. PLoS One. 2011;6(2):e17174.
31. Bramlage P, Schindler C. Differences in pharmacology and their translation into differences in clinical efficacy -a comparison of the renin angiotensin blocking agents irbesartan and losartan. Expert Opin Pharmacother. 2010;11(4):521-535.
32. Steckelings UM, Paulis L, Namsolleck P, Unger T. AT2 receptor agonists: hypertension and beyond. Curr Opin Nephrol Hypertens. 2012;21(2):142-146.
33. Walsh SV, Hopkins AM, Nusrat A. Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev. 2000;41(3):303-313.
34. Seydel KB, et al. Brain swelling and death in children with cerebral malaria. N Engl J Med. 2015;372(12):1126-1137.
35. Stamatovic SM, Keep RF, Andjelkovic AV. Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol. 2008;6(3):179-192.
36. Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J. 2012;31(12):2714-2736.
37. Conroy AL, et al. Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study∗. Crit Care Med. 2012;40(3):952-959.
38. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol. 2009;29(8):2011-2022.
39. Conroy AL, et al. Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J. 2009;8:295.
40. Lovegrove FE, et al. Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One. 2009;4(3):e4912.
41. Yeo TW, et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A. 2008;105(44):17097-17102.
42. Yu C, Luo X, Duquette N, Thorin-Trescases N, Thorin E. Knockdown of angiopoietin like-2 protects against angiotensin II-induced cerebral endothelial dysfunction in mice. Am J Physiol Heart Circ Physiol. 2015;308(5):H386-H397.
43. Otani A, Takagi H, Oh H, Koyama S, Honda Y. Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes. 2001;50(4):867-875.
44. Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res. 2003;93(5):438-447.
45. Hansen TM, Moss AJ, Brindle NP. Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke. Curr Neurovasc Res. 2008;5(4):236-245.
46. Newton CR, Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther. 1998;79(1):1-53.
47. Malaria Treatment (United States). Center for Disease Control and Prevention. https://www.cdc.gov/malaria/diagnosis-treatment/treatment.html. Updated June 10, 2015. Accessed July 18, 2016.
48. Danyel LA, Schmerler P, Paulis L, Unger T, Steckelings UM. Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure. Integr Blood Press Control. 2013;6:153-161.
49. Fedson DS, Rordam OM. Treating Ebola patients: a 'bottom up' approach using generic statins and angiotensin receptor blockers. Int J Infect Dis. 2015;36:80-84.
50. Krump-Konvalinkova V, Bittinger F, Unger RE, Peters K, Lehr HA, Kirkpatrick CJ. Generation of human pulmonary microvascular endothelial cell lines. Lab Invest. 2001;81(12):1717-1727.
51. Maul B, et al. Impaired spatial memory and altered dendritic spine morphology in angiotensin II type 2 receptor-deficient mice. J Mol Med. 2008;86(5):563-571.
52. Gembardt F, et al. Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors. FASEB J. 2008;22(8):3068-3077.
53. Waknine-Grinberg JH, et al. Artemisone effective against murine cerebral malaria. Malar J. 2010;9:227.
54. Wilcox R, Carlson M, Azen S, Clark F. Avoid lost discoveries, because of violations of standard assumptions, by using modern robust statistical methods. J Clin Epidemiol. 2013;66(3):319-329.
55. Wilcox RR, Keselman HJ. Modern regression methods that can substantially increase power and provide a more accurate understanding of associations. Eur J Pers. 2012;26(3):165-174.